Format

Send to

Choose Destination
Int J Spine Surg. 2015 Jul 27;9:41. doi: 10.14444/2041. eCollection 2015.

Percutaneous Transforaminal Lumbar Interbody Fusion (pTLIF) with a Posterolateral Approach for the Treatment of Denegerative Disk Disease: Feasibility and Preliminary Results.

Author information

1
Orthopedic Spine Surgery Unit (Morgenstern Spine Institute), Hospital Quirón Teknon, Barcelona, Spain.
2
Centrum für Musculoskeletale Chirurgie (CMSC), Department of Orthopedic Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany.

Abstract

BACKGROUND:

Interbody fusion by open discectomy is the usual treatment for degenerative disk disease but requires a relatively long recovery period. The transforaminal posterolateral approach is a well-known standard in endoscopic spine surgery that allows direct access to the disk with progressive tissue dilation. The aim of this study was to assess the feasibility of percutaneous transforaminal interbody fusion (pTLIF) with insertion of an expandable or a standard rigid interbody implant for patients with degenerative disk disease with or without spondylolisthesis and for revision surgery.

METHODS:

Between 2009 and 2014, the pTLIF procedure was performed in 30 patients. Ten patients underwent insertion of a rigid implant (group A) and the remaining 20 underwent insertion of an expandable titanium interbody implant as the initial procedure (n = 10) (group B) or after failed back surgery (n = 10) (group C). Patient outcomes were scored with visual analogic scale (VAS), Oswestry disability index (ODI) and modified Macnab criteria.

RESULTS:

The mean follow-up period was 38 (17) (range 11 to 67) months. The outcome was excellent in 18, good in 10 and fair in 2. No poor results and no major complications were reported. No differences in VAS and ODI scores according to the study group were found. Median postoperative time until hospital discharge was 26 hours (20 to 68 hours). Postoperative values for VAS and ODI scores improved significantly (p<0.05) compared to preoperative data in all study groups.

CONCLUSIONS:

These preliminary results have shown the feasibility and efficacy of the pTLIF procedure using a posterolateral approach for the treatment of degenerative disk disease with or without spondylolisthesis up to grade 2 and in revision surgery. No significant differences in outcome were observed between an expandable and a rigid cage. Median postoperative time until hospital discharge was faster compared to standard TLIF (26 hours vs. 9.3 days).

KEYWORDS:

Minimally invasive surgery; degenerative disk disease; expandable titanium interbody implant; percutaneous transforaminal lumbar interbody fusion; revision surgery; transforaminal posterolateral approach

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center